{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:12:06Z","timestamp":1790691126280,"version":"4.1.0"},"reference-count":124,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T00:00:00Z","timestamp":1524614400000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Hemodialysis International"],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic hepatitis C virus (HCV) infection is an infection that affects over 71 million people worldwide that primarily leads to significant morbidity and mortality through its predisposition to liver fibrosis, cirrhosis, and liver cancer. In addition, extrahepatic manifestations, such as mixed cryoglobulinaemia\u2010associated vasculitis including renal disease, or type II diabetes are frequently encountered in chronically infected individuals. HCV treatment aims to permanently eradicate the virus in order to prevent both liver and extra\u2010hepatic manifestations. Over two decades after the HCV discovery, treatments have evolved from nonspecific immune modulating therapies based on interferon to specific drug combinations, targeting viral proteins. In the present review, we give an overview of HCV infection with a special emphasis on the history of the treatment of viral hepatitis C and the substantial improvement in efficacy and tolerability profile with the recent development of new direct\u2010acting antiviral therapies.<\/jats:p>","DOI":"10.1111\/hdi.12647","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T13:50:47Z","timestamp":1524664247000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Introduction to hepatitis C virus infection: Overview and history of hepatitis C virus therapies"],"prefix":"10.1111","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8213-5440","authenticated-orcid":false,"given":"Lorena","family":"Puchades Renau","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Hepatology Unit &amp; Instituto de Investigaci\u00f3n La Fe Hospital Universitari i Polit\u00e8cnic La Fe Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Berenguer","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology Unit &amp; Instituto de Investigaci\u00f3n La Fe Hospital Universitari i Polit\u00e8cnic La Fe Valencia Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd) Valencia Spain"},{"name":"School of Medicine University of Valencia Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,4,25]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"WHO.Hepatitis C. Geneva: Author 2017. Available from:http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/(accessed date: February 13 2018)."},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis385"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.107"},{"key":"e_1_2_7_6_1","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.1840360713","article-title":"Sexual activity as a risk factor for hepatitis C","volume":"36","author":"Terrault NA.","year":"2002","journal-title":"Hepatology."},{"key":"e_1_2_7_7_1","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1002\/hep.1840360714","article-title":"Maternal\u2010infant transmission of hepatitis C virus infection","volume":"36","author":"Roberts EA","year":"2002","journal-title":"Hepatology."},{"key":"e_1_2_7_8_1","unstructured":"BenllochS Rodr\u00edguezB \u00c1lvarez\u2010Navascu\u00e9sC Rodr\u00edguezM BerenguerM.Hepatitis V\u00edricas. Editorial CTO;2015."},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2015.05.004"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.09.001"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.07.012"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.12.014"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ860"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.144878"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.08.035"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.02.017"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2015.07.006"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.08.026"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.10.6532"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23031"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.11.050"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hep.2003.09.012"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1586\/egh.11.43"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12676"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.90"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25508"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12184"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.12.1271"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(92)90036-O"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2015.5"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh1020"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016010030"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2001.10212.x"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.04.030"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2010.12.009"},{"key":"e_1_2_7_36_1","unstructured":"American Association for the Study of Liver Diseases (AASLD).HCV Guidance: Recommendations for Testing Managing and Treating Hepatitis C.2017. Available from:https:\/\/www.hcvguidelines.org\/evaluate\/testing-and-linkage(accessed date: February 13 2018)."},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.19082\/5646"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP3042"},{"key":"e_1_2_7_39_1","first-page":"S1","article-title":"KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease","volume":"109","author":"Kidney Disease: Improving Global Outcomes (KDIGO)","year":"2008","journal-title":"Kidney Int Suppl"},{"key":"e_1_2_7_40_1","first-page":"1","article-title":"Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention","volume":"52","author":"Alter MJ","year":"2003","journal-title":"MMWR Recomm Rep."},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2008.02.015"},{"key":"e_1_2_7_42_1","first-page":"362","article-title":"Testing for HCV infection: An update of guidance for clinicians and laboratorians","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i17.2461"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.06038.x"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.116"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23444"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.07.009"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308163"},{"key":"e_1_2_7_49_1","unstructured":"American Association for the Study of Liver Diseases (AASLD).When And In Whom To Initiate HCV Therapy.2017. Available fromwww.HCVGuidance.org(accessed date: February 13 2018)."},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198911303212203"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2003.30113.x"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/cld.1"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811193392101"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07124-4"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.21747"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012073432301"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.26371"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06102-5"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020047"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-5-200403020-00010"},{"key":"e_1_2_7_61_1","first-page":"218","article-title":"Mechanism of action of ribavirin in the treatment of chronic hepatitis C","volume":"3","author":"Te HS","year":"2007","journal-title":"Gastroenterol Hepatol (N Y)."},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2013.01.041"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.02.037"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23192"},{"key":"e_1_2_7_65_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-015-0261-0"},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12145"},{"key":"e_1_2_7_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.04.035"},{"key":"e_1_2_7_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512610"},{"key":"e_1_2_7_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0817-y"},{"key":"e_1_2_7_70_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1213651"},{"key":"e_1_2_7_71_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5386.103"},{"key":"e_1_2_7_72_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.8.3392"},{"key":"e_1_2_7_73_1","doi-asserted-by":"publisher","DOI":"10.3390\/v7122968"},{"key":"e_1_2_7_74_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.03.003"},{"key":"e_1_2_7_75_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214853"},{"key":"e_1_2_7_76_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214854"},{"key":"e_1_2_7_77_1","first-page":"733A","article-title":"Sofosbuvir \u00fe ribavirin for 12 or 24 weeks for patients with HCV genotype 2 or 3: The VALENCE trial","volume":"58","author":"Zeuzem S","year":"2013","journal-title":"Hepatology."},{"key":"e_1_2_7_78_1","first-page":"1379A","article-title":"SVR results of a once\u2010daily regimen of simeprevir (TMC435) plus sofosbuvir (GS\u20107977) with or without ribavirin in cirrhotic and non\u2010cirrhotic HCV genotype 1 treatmentna\u00efve and prior null responder patients: The COSMOS study","volume":"58","author":"Jacobson I","year":"2013","journal-title":"Hepatology."},{"key":"e_1_2_7_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13883"},{"key":"e_1_2_7_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13470"},{"key":"e_1_2_7_81_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306218"},{"key":"e_1_2_7_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27726"},{"key":"e_1_2_7_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28473"},{"key":"e_1_2_7_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27890"},{"key":"e_1_2_7_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00157-7"},{"key":"e_1_2_7_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28706"},{"key":"e_1_2_7_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00529-0"},{"key":"e_1_2_7_88_1","first-page":"1274A","article-title":"High efficacy of LDV\/SOF regimens for 12 weeks for patients with HCV genotype 3 or 6 infection","volume":"60","author":"Gane EJ","year":"2014","journal-title":"Hepatology."},{"key":"e_1_2_7_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.01.028"},{"key":"e_1_2_7_90_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315722"},{"key":"e_1_2_7_91_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402338"},{"key":"e_1_2_7_92_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402869"},{"key":"e_1_2_7_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(14)60060-X"},{"key":"e_1_2_7_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30001-2"},{"key":"e_1_2_7_95_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512612"},{"key":"e_1_2_7_96_1","first-page":"554A","article-title":"Predictors of response to grazoprevir\/elbasvir among HCV genotype 1 (GT1)\u2010infected patients: Integrated analysis of Phase 2\u20133 trials","volume":"62","author":"Zeuzem S","year":"2015","journal-title":"Hepatology."},{"key":"e_1_2_7_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(15)31088-6"},{"key":"e_1_2_7_98_1","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0785"},{"key":"e_1_2_7_99_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613512"},{"key":"e_1_2_7_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.039"},{"key":"e_1_2_7_101_1","first-page":"S1542","article-title":"Efficacy of glecaprevir\/pibrentasvir for 8 or 12 weeks in patients with hepatitis C virus genotype 2, 4, 5, or 6 infection without cirrhosis","author":"Asselah T","year":"2017","journal-title":"Clin Gastroenterol Hepatol."},{"key":"e_1_2_7_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00052-9"},{"key":"e_1_2_7_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.06.019"},{"key":"e_1_2_7_104_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512614"},{"key":"e_1_2_7_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.05.010"},{"key":"e_1_2_7_106_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001633"},{"key":"e_1_2_7_107_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27681"},{"key":"e_1_2_7_108_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.10.001"},{"key":"e_1_2_7_109_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.05.010"},{"key":"e_1_2_7_110_1","first-page":"3","article-title":"An interferon\u2010free antiviral regimen for HCV after liver transplantation","volume":"98","author":"Kwo PY","year":"2014","journal-title":"N Engl J Med."},{"key":"e_1_2_7_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.05.039"},{"key":"e_1_2_7_112_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13102"},{"key":"e_1_2_7_113_1","unstructured":"Clinical Trial NCT01958281. Available from:https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01958281?term=%22sofosbuvir%22\u00b1AND\u00b1%22renal%22+AND+%22impairment%22&rank=1(accessed date: February 13 2018)."},{"key":"e_1_2_7_114_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.078"},{"key":"e_1_2_7_115_1","first-page":"143829","article-title":"RUBY\u2010II: Efficacy and Safety of a Ribavirin\u2010free Ombitasvir\/Paritaprevir\/Ritonavir\u2009\u00b1\u2009Dasabuvir Regimen in Patients with Severe Renal Impairment or End\u2010Stage Renal Disease and HCV Genotypes 1a or 4 Infection","year":"2016","journal-title":"AASLD LiverLearning\u00ae."},{"key":"e_1_2_7_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00349-9"},{"key":"e_1_2_7_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(17)30116-4"},{"key":"e_1_2_7_118_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704053"},{"key":"e_1_2_7_119_1","doi-asserted-by":"publisher","DOI":"10.7326\/M16-1205"},{"key":"e_1_2_7_120_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29258"},{"key":"e_1_2_7_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.12.020"},{"key":"e_1_2_7_122_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28923"},{"key":"e_1_2_7_123_1","doi-asserted-by":"crossref","unstructured":"S\u00e1ez\u2010Gonz\u00e1lezE VinaixaC San JuanF HontangasV BenllochS AguileraV Rub\u00ednA Garc\u00edaM PrietoM L\u00f3pez\u2010And\u00fajarR BerenguerM. Impact of Hepatitis C Virus (HCV) Antiviral Treatment on the Need for Liver Transplantation (LT).Liver Int.2017. [PMID: 29105320; doi: 10.1111\/liv.13618].","DOI":"10.1111\/liv.13618"},{"key":"e_1_2_7_124_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.2.283"},{"key":"e_1_2_7_125_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.31773"}],"container-title":["Hemodialysis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhdi.12647","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hdi.12647","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T22:56:31Z","timestamp":1751583391000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hdi.12647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":124,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.1111\/hdi.12647"],"URL":"https:\/\/doi.org\/10.1111\/hdi.12647","archive":["Portico"],"relation":{},"ISSN":["1492-7535","1542-4758"],"issn-type":[{"value":"1492-7535","type":"print"},{"value":"1542-4758","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"2017-10-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}